ESLA — Estrella Immunopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $41.97m
- $40.17m
Annual cashflow statement for Estrella Immunopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1.69 | -11.1 | -7.31 |
| Non-Cash Items | 0.13 | 0.41 | 1.19 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.113 | 9.37 | -9.95 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Cash from Operating Activities | -1.44 | -1.34 | -16.1 |
| Other Investing Cash Flow Items | — | -0.273 | 4.96 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | -0.273 | 4.96 |
| Financing Cash Flow Items | 0.515 | — | 4.13 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 5.53 | — | 12.8 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 4.09 | -1.61 | 1.69 |